Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $29.6B
1-Year Est. Return 20.82%
This Quarter Est. Return
1 Year Est. Return
+20.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$27.1B
AUM Growth
+$3.44B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,358
New
Increased
Reduced
Closed

Top Buys

1 +$165M
2 +$114M
3 +$97.6M
4
MAA icon
Mid-America Apartment Communities
MAA
+$87.8M
5
AMZN icon
Amazon
AMZN
+$82.2M

Top Sells

1 +$135M
2 +$118M
3 +$97M
4
UDR icon
UDR
UDR
+$79.3M
5
AVB icon
AvalonBay Communities
AVB
+$73.5M

Sector Composition

1 Real Estate 30.73%
2 Technology 27.75%
3 Communication Services 10.3%
4 Consumer Discretionary 6.75%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLU icon
1226
State Street Utilities Select Sector SPDR ETF
XLU
$21.7B
$2K ﹤0.01%
+20
XNCR icon
1227
Xencor
XNCR
$1.24B
$2K ﹤0.01%
222
ZVRA icon
1228
Zevra Therapeutics
ZVRA
$491M
$2K ﹤0.01%
182
AVBP icon
1229
ArriVent BioPharma
AVBP
$945M
$2K ﹤0.01%
111
TECX
1230
Tectonic Therapeutic
TECX
$378M
$2K ﹤0.01%
80
ALLO icon
1231
Allogene Therapeutics
ALLO
$342M
$1K ﹤0.01%
535
-30,290
ALT icon
1232
Altimmune
ALT
$533M
$1K ﹤0.01%
235
AMRN
1233
Amarin Corp
AMRN
$339M
$1K ﹤0.01%
66
-1
ANNX icon
1234
Annexon
ANNX
$638M
$1K ﹤0.01%
352
ARCT icon
1235
Arcturus Therapeutics
ARCT
$187M
$1K ﹤0.01%
90
ATXS icon
1236
Astria Therapeutics
ATXS
$747M
$1K ﹤0.01%
186
AURA icon
1237
Aura Biosciences
AURA
$400M
$1K ﹤0.01%
165
AUTL
1238
Autolus Therapeutics
AUTL
$394M
$1K ﹤0.01%
575
-22,352
AVIR icon
1239
Atea Pharmaceuticals
AVIR
$241M
$1K ﹤0.01%
242
BCYC
1240
Bicycle Therapeutics
BCYC
$495M
$1K ﹤0.01%
103
CDXS icon
1241
Codexis
CDXS
$153M
$1K ﹤0.01%
269
CMPS
1242
Compass Pathways
CMPS
$489M
$1K ﹤0.01%
+327
CRGX
1243
DELISTED
CARGO Therapeutics
CRGX
$1K ﹤0.01%
152
DSGN icon
1244
Design Therapeutics
DSGN
$557M
$1K ﹤0.01%
350
EDIT icon
1245
Editas Medicine
EDIT
$231M
$1K ﹤0.01%
277
ERAS icon
1246
Erasca
ERAS
$933M
$1K ﹤0.01%
1,074
ESPR icon
1247
Esperion Therapeutics
ESPR
$896M
$1K ﹤0.01%
650
EYPT icon
1248
EyePoint Pharmaceuticals
EYPT
$1.2B
$1K ﹤0.01%
144
FDMT icon
1249
4D Molecular Therapeutics
FDMT
$611M
$1K ﹤0.01%
184
-9,394
GLPG icon
1250
Galapagos
GLPG
$2.09B
$1K ﹤0.01%
51